Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-099000
Filing Date
2024-08-20
Accepted
2024-08-20 13:34:59
Documents
17
Effectiveness Date
2024-08-20

Document Format Files

Seq Description Document Type Size
1 S-8 neog-20240819.htm S-8 138236
2 EX-5.1 neog-ex5_1.htm EX-5.1 13363
3 EX-23.1 neog-ex23_1.htm EX-23.1 4460
4 EX-FILING FEES neog_exfilingfees.htm   iXBRL EX-FILING FEES 47517
5 GRAPHIC img252587657_0.jpg GRAPHIC 15562
6 GRAPHIC img252587657_1.jpg GRAPHIC 7073
  Complete submission text file 0000950170-24-099000.txt   369536

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT neog_exfilingfees_htm.xml XML 7097
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: S-8 | Act: 33 | File No.: 333-281655 | Film No.: 241224170
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)